Hence, B-TACE showed a trend of better oncological response over DEM-TACE with and longer TTR with a similar adverse events rate, in patients presenting with larger tumors ( 40 ).
← all excerpts
Efficacy and features of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: a narrative review.
1
—
—